Medtronic Escapes 3 Shareholder Suits Over Infuse Device
Three shareholder derivative suits filed in Minnesota state court against current and former executives of Medtronic PLC in connection with off-label use of its Infuse bone graft device were voluntarily dismissed...To view the full article, register now.
Already a subscriber? Click here to view full article